TREM2and Neurodegenerative Disease
Year: 2013
Type: article
Study design: Observational Study
Abstract: We and other members of the Alzheimer’s Disease Genetics Consortium assembled multiple data sets from a total of 5896 black patients (1968 cases and 3928 controls). First, the association of Alzheimer’s disease with genotyped and imputed SNPs was individually assessed in each data set with the use of logistic regression for case–control data sets and generalized estimating equations for family-based data sets (with adjustment for age, sex, the presence or absence of the apolipoprotein E [APOE] e4 allele, and population stratification). The results from the individual data sets were combined in a genomewide inverse-variance-weighted meta-analysis. Subsequently, a versatile gene-based association study (VEGAS)3 was performed specifically to explore the association of the TREM2 gene with Alzheimer’s disease; the addition of 20 kb to each side yielded a list of SNPs (see the Supplementary Appendix, available with the full text of this letter at NEJM.org). With the use of simulation based on the linkage-disequilibrium structure of a group of reference samples from HapMap, VEGAS allowed us to calculate the empirical P value for associations between disease status and variants in TREM2 while taking into account gene size and linkage disequilibrium between the markers.3
Source: New England Journal of Medicine
DOI: 10.1056/nejmc1306509
Authors: Christiane Reitz, Richard Mayeux
Institution: Columbia University
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Funders: National Institutes of Health, National Institute on Aging, National Institute of Mental Health, National Human Genome Research Institute, National Institute of Neurological Disorders and Stroke, National Institute of Biomedical Imaging and Bioengineering, National Center for Advancing Translational Sciences
Awards: Epidemiologic Study of Neural Reserve and Neurobiology of Aging, Identifying Rare Variants that Increase Risk for Alzheimer's Disease, UC Davis Alzheimer's Disease Core Center, Epidemiology of Biomarkers of Risk and Progression in LOAD, Gene discovery in PSP by transcriptome, neuropathology and sequence analysis, Alzheimer's Disease Patient Registry (ADPR/ACT), National Alzheimer's Coordinating Center, UCSD Alzheimer's Disease Research Center P50, Mapping Causative factors in the sortilin-related pathway in Alzheimer's Disease, Alzheimer's Disease Research Center, Washington University Center for Translational Neuroscience, UCLA Alzheimer's Disease Research Center, "MR Morphometrics and Cognitive Decline Rate in Large-Scale Aging Studies", Imaging and genetic biomarkers for Alzheimer's disease, The Alzheimer's Disease Research Center at the University of California, Irvine, Alzheimer's disease risk analyzed using population imaging genomics, Risk Factors, Pathology, and Clinical Expressions of AD, Empowering Personalized Medicine: Integrating Imaging, Genetics, and Biomarkers, A Multidimensional Alzheimer's Disease Brain Atlas, Alzheimer's Disease Genetics Consortium, Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Core Center, Alzheimer's Disease Research Center - Overall, IDENTIFYING RARE VARIANTS THAT INCREASE RISK FOR ALZHEIMER'S DISEASE, Genetic Discovery and Application in a Clinical Setting Continuing a Partnership, MECHANISMS OF DEEP BRAIN STIMULATION, Investigations of Dementia in Parkinson Disease, Washington University Institute of Clinical and Translational Sciences, Translational Neuroscientist and the Hope Center, Boston University Alzheimer's Disease Center, Massachusetts Alzheimer's Disease Research Center, Laboratory of Neuro Imaging Resource (LONIR), Predicting Brain Changes in HIV/AIDS, Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease, National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), Massachusetts Alzheimer's Disease Research Center (MADRC)
OpenAlex ID: W1585245628
